Membranous septum length may not be the answer

Affiliations

Comment

Hiroki Ueyama et al. Catheter Cardiovasc Interv. 2022 Nov.

. 2022 Nov;100(5):877-878.

doi: 10.1002/ccd.30456.

¹ Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA.

No abstract available

Keywords: AVD, aortic valve disease; AVDP, aortic valve disease; IMAG, imaging (CT/MR); percutaneous intervention.

Comment on

Validation of reliability and predictivity of membrane septum length measurements for pacemaker need after transcatheter aortic valve replacement.
Hioki H, Watanabe Y, Kozuma K, Ryuzaki T, Goto S, Inohara T, Katsumata Y, Tsunaki T, Kawahata R, Kobayashi T, Asami M, Otsuka T, Yamamoto M, Hayashida K; OCEAN-TAVI Investigators. Hioki H, et al. Catheter Cardiovasc Interv. 2022 Nov;100(5):868-876. doi: 10.1002/ccd.30377. Epub 2022 Sep 7. Catheter Cardiovasc Interv. 2022. PMID: 36073020

1. Hamdan A, Guetta V, Klempfner R, et al. Inverse relationship between membranous septal length and the risk of atrioventricular block in patients undergoing transcatheter aortic valve implantation. JACC: Cardiovascular Interventions. 2015;8(9):1218-1228.
1. Jilaihawi H, Zhao Z, Du R, et al. Minimizing permanent pacemaker following repositionable self-expanding transcatheter aortic valve replacement. JACC: Cardiovascular Interventions. 2019;12(18):1796-1807.
1. Nai Fovino L, Cipriani A, Fabris T, et al. Anatomical predictors of pacemaker dependency after transcatheter aortic valve replacement. Circ Arrhythm Electrophysiol. 2021;14(1):e009028.
1. Chen YH, Chang HH, Liao TW, et al. Membranous septum length predicts conduction disturbances following transcatheter aortic valve replacement. J Thorac Cardiovasc Surg. 2022;164(1):42-51.e2.